U.S. Tech Hardware Stock News

If you are wondering whether ICON's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Over shorter timeframes, ICON's share price has moved only modestly, with a 0.7% return over the last week and 1.8% over the last month, while the year to date return of 3.2% decline and 1 year return of 7.8% decline contrast with a 21.1% decline over 3 years and 15.6% decline over 5 years. These returns sit...

If you are wondering whether RTX is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about future value. RTX recently closed at US$201.92, with returns of 7.1% over 7 days, 14.0% over 30 days, 7.8% year to date, 69.8% over 1 year, 129.0% over 3 years and 235.1% over 5 years. This naturally raises questions about how much optimism is already reflected in the stock. Recent headlines around RTX have focused on the company...

Citizens Financial Group previously announced that it would release its fourth quarter and full-year 2026 results on January 15, 2027, with a press release at approximately 6:20 a.m. Eastern and a conference call at 9:00 a.m., both accessible via its investor relations website. Beyond the timing update, Citizens has outlined an ambitious plan centered on substantial projected earnings growth, expanding private banking, expiring legacy interest rate hedges, and efficiency gains from AI, all...

Why CVS Health Stock Is Back in Focus After Its Latest Dividend Decision CVS Health (CVS) is drawing fresh attention after its board approved a quarterly dividend of $0.665 per share, payable on February 2, 2026, to shareholders of record on January 22. This latest dividend affirmation comes as investors weigh the company’s broad health solutions model, recent commentary around Medicare Advantage exposure, and expectations heading into the upcoming fourth quarter 2025 earnings release. See...

Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has helped lift investor interest in the stock. See our latest analysis for Oddity Tech. At a share price of $35.34, Oddity Tech has seen a 4.56% 1 day share price return, but weaker 30 day and 90 day share price returns of 16.34% and 30.50%, with a 1 year total shareholder return of 19.39%. This...

Membership surge and profitability target come into focus Clover Health Investments (CLOV) recently reported a 53% year over year jump in Medicare Advantage membership to about 153,000 members, alongside guidance for its first full year of GAAP net income profitability in 2026. Management links this outlook to stronger member retention above 95%, improved operational efficiencies, and higher Star Ratings. Its flagship PPO plan is highlighted as a key contributor during a period of wider...

Why Quaker Chemical Is On Investors’ Radar Today Quaker Chemical (KWR) has drawn fresh attention after a recent share move, with the stock up about 13% over the past month and roughly 21% in the past 3 months. See our latest analysis for Quaker Chemical. The recent 12.97% 1 month share price return and 21.04% 3 month share price return suggest momentum has picked up again, even though the 5 year total shareholder return of a 39.05% loss shows a much tougher longer term journey. If Quaker...

If you are wondering whether Compass is still reasonably priced after a strong run, this article will walk you through what the current share price could imply about its underlying value. The stock closed at US$12.86, with returns of 0.2% over the last 7 days, 22.1% over the last 30 days, 22.5% year to date and 90.2% over the last year, so recent moves are front of mind for many investors. Recent news coverage has focused on Compass as a listed real estate brokerage platform, highlighting...

Why Brookdale’s latest occupancy and refinancing updates matter Brookdale Senior Living (BKD) has drawn fresh investor attention after reporting higher fourth quarter 2025 occupancy and above seasonal December performance, alongside a US$600 million refinancing that reshapes its near term debt profile. See our latest analysis for Brookdale Senior Living. The refinancing news and occupancy gains have come alongside a sharp shift in sentiment, with an 8.44% 1 day share price return, a 40.55% 90...

Earlier this week, MongoDB, Inc. expanded its AI capabilities by integrating Voyage AI’s embedding and reranking models directly into its core database and Atlas platform, while also launching automated embedding tools, multimodal support including video, and an AI assistant for Compass and Atlas Data Explorer. This move effectively turns MongoDB into a more unified data intelligence layer, allowing developers to keep operational data and vector search together, simplify architectures, and...

GE HealthCare Technologies (GEHC) is back in focus after announcing a collaboration with NXP Semiconductors to bring edge AI into acute care, including new anesthesia and neonatal monitoring concepts showcased at CES 2026. See our latest analysis for GE HealthCare Technologies. At a share price of $81.75, GE HealthCare’s recent momentum has cooled, with a 7 day share price return of 6.34% decline and a 30 day share price return of 0.93% decline. However, the 90 day share price return of...

Minerals Technologies Inc. recently expanded its paper and packaging business in Asia by starting up three new satellite plants in 2025, doubling capacity at an existing Indian facility, and planning to commission another satellite in China in early 2026, deepening its presence across China, India, Indonesia, Japan, and Thailand. An interesting angle is that about half of these new and expanded Asian satellites are dedicated to packaging applications, aligning the business more closely with...

Conference spotlight and why investors are watching LightPath Technologies (LPTH) is set to present at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, and that upcoming appearance is drawing fresh attention from investors. See our latest analysis for LightPath Technologies. That conference appearance comes after a sharp run in the shares, with a 30 day share price return of 82.70% and a 1 year total shareholder return of 273.00%. This suggests...

Sify Technologies Limited has released its third-quarter 2025 results, reporting sales of ₹11,596 million versus ₹10,491 million a year earlier, alongside a net loss of ₹329 million compared with ₹258 million previously. Beyond the headline loss, the company’s 11% revenue increase and strong demand for data center co-location capacity highlight how its AI and hyperscaler-focused infrastructure build-out is reshaping its business mix. We’ll now examine how this combination of higher revenue...

Lindsay Corporation recently reported first-quarter 2026 results showing sales of US$155.82 million and net income of US$16.52 million, while its Board declared a regular quarterly dividend of US$0.37 per share payable on February 27, 2026, and appointed long-time finance executive Brett R. Coburn as Chief Accounting Officer. Together, stable earnings, continued cash returns via the dividend, and internal promotion to a key finance role highlight management’s focus on financial discipline...

Leidos Holdings context for investors Leidos Holdings (LDOS) has drawn investor attention recently as its shares trade around $194.70, with performance over the past month and past 3 months adding context to the defense and technology contractor’s current valuation. See our latest analysis for Leidos Holdings. At a share price of $194.70, Leidos’ recent 7.4% 1 month share price return and 6.1% year to date share price return sit alongside a 1 year total shareholder return of 26.8% and a 3...

Stock performance snapshot and context SM Energy (SM) has drawn investor attention after a period of weak share performance, with the stock showing a 56.1% negative total return over the past year and a 41.2% negative total return over three years. See our latest analysis for SM Energy. At a recent share price of $18.21, SM Energy has seen pressure on its short term share price performance, with a 30 day share price return of a 6.18% decline and a 90 day share price return of a 14.35%...

American States Water (AWR) is back in focus after its Golden State Water subsidiary received approval for a $32 million rate increase from the California Public Utilities Commission, effective January 1, 2026. See our latest analysis for American States Water. The approved 2026 rate increase comes as American States Water’s share price sits at $75.97, with a 7 day share price return of 3.78% and a year to date share price return of 5.13%. The 1 year total shareholder return of 4.09%...

ACADIA Pharmaceuticals (ACAD) recently outlined its long term sales outlook at the 44th Annual J.P. Morgan Healthcare Conference, linking projected net sales above US$1b by 2025 and about US$1.7b by 2028 to its neurology portfolio. See our latest analysis for ACADIA Pharmaceuticals. The recent J.P. Morgan update, together with upcoming events like the DAYBUE STIX launch and the Biotech Showcase presentation in San Francisco, comes after a 24.4% 90 day share price return and a 47.9% 1 year...

Event context and recent share performance Huntsman (HUN) has been drawing attention after a stretch of mixed share performance, with a gain of 18.15% over the past month and a 28.68% decline over the past 1 year. See our latest analysis for Huntsman. For Huntsman, the recent 44.89% 3 month share price return contrasts with a 28.68% 1 year total shareholder return decline. This suggests short term momentum has picked up while longer term returns remain under pressure. If Huntsman’s mixed...

Starbucks, now led by CEO Brian Niccol, has begun executing its “Back to Starbucks” and Green Apron initiatives, recently returning to positive comparable-store sales while also addressing a high-profile public relations incident and ongoing waste and sustainability concerns. At the same time, Starbucks is reshaping its global footprint by selling most of its China stake and preparing to report first-quarter fiscal 2026 results, developments that could influence how investors judge the early...

Why EVERTEC (EVTC) is on investors’ radar today EVERTEC (EVTC) has drawn investor attention after its latest financial metrics highlighted solid transaction processing activity across Latin America and the Caribbean, with annual revenue of US$903.381m and net income of US$146.091m. Those headline figures, combined with mixed recent share returns and an assigned value score of 5, are prompting investors to reassess how this regional payments and fintech provider fits into a diversified...

Regulatory catalyst and expanding oncology reach Zai Lab (ZLAB) has drawn fresh investor attention after China’s National Medical Products Administration approved a supplemental New Drug Application for AUGTYRO (repotrectinib) in NTRK fusion positive solid tumors, which broadens its potential treatment reach. See our latest analysis for Zai Lab. Despite the recent product approvals and pipeline updates, Zai Lab’s share price at US$18.58 reflects mixed momentum, with a 30 day share price...

Wondering if UMB Financial at around US$122 per share is offering fair value right now, or if the price is leaving some upside on the table for patient investors? The stock has recently shown steady returns, with about 0.4% over the last week, 2.6% over the last month, 4.8% year to date and 3.6% over the past year, adding to longer term returns of 51.2% over three years and 76.6% over five years. Recent coverage of UMB Financial has focused on how investors are reassessing bank stocks more...